Yoo; Nae Choon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yoo; Nae Choon.The latest application filed is for "antibody to a mutant g-csf for diagnosis of cancer".

Company Profile

1.2.23

Yoo; Nae Choon - Seoul KR
Yoo, Nae Choon - Yuonhui dong RU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody To A Mutant G-csf For Diagnosis Of Cancer App 20140005365 - Lee; Sang Yup ; et al.	2014-01-02
Method Of Diagnosing Cancer Using G-csf Protein Having A Deletion Of An Amino Acid Sequence Corresponding To Exon 3 As A Diagnostic Cancer Marker App 20120329078 - LEE; SANG YUP ; et al.	2012-12-27
G-csf Protein Having A Deletion Of An Amino Acid Sequence Corresponding To Exon 3 For Use As A Diagnostic Cancer Marker App 20120322684 - Lee; Sang Yup ; et al.	2012-12-20
Microarray for detection of the deletion of exon 3 of the G-CSF gene Grant 8,324,363 - Lee , et al. December 4, 2	2012-12-04
Method of treating a wound with acidified plasma or serum Grant 8,017,157 - Yoo , et al. September 13, 2	2011-09-13
Pharmaceutical Composition For Treating Avellino Cornea Dystrophy Comprising An Antibody Against Tgf-beta App 20100322947 - Kim; Eung Kweon ; et al.	2010-12-23
Diagnostic Method For Cancer Characterized In The Detection Of The Deletion Of G-csf Exon 3 App 20100286381 - LEE; Sang Yup ; et al.	2010-11-11
Dna Chip For Detection Of Escherichia Coli App 20100167956 - LEE; Sang Yup ; et al.	2010-07-01
Dna Chip For Detection Of Staphylococcus Aureus App 20100167951 - Lee; Sang Yup ; et al.	2010-07-01
Dna Chip For Diagnosis Of Corneal Dystrophy App 20090305394 - Lee; Sang Yup ; et al.	2009-12-10
Marker And Method For Cancer Diagnosis App 20090269750 - Lee; Sang Yup ; et al.	2009-10-29
Pharmaceutical Composition For The Treatment Of Nerve Damage Comprising Blood Plasma Or Serum App 20090136587 - Yoo; Won Min ; et al.	2009-05-28
Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising Blood Plasma or Serum App 20080299212 - Kim; Eung Kweon ; et al.	2008-12-04
Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising an Antibody Against Tgf-Beta App 20080267946 - Kim; Eung Kweon ; et al.	2008-10-30
Compositions for Treating Alopecia or Promoting Hair Growth App 20080193386 - Yoo; Won-Min ; et al.	2008-08-14
Pharmaceutical composition for treatment of wounds containing blood plasma or serum App 20070148142 - Yoo; Won Min ; et al.	2007-06-28
Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 App 20050266430 - Lee, Sang Yup ; et al.	2005-12-01
Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 App 20050244856 - Lee, Sang Yup ; et al.	2005-11-03
Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 App 20050170416 - Lee, Sang Yup ; et al.	2005-08-04
Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 App 20050170417 - Lee, Sang Yup ; et al.	2005-08-04
Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 App 20050158810 - Lee, Sang Yup ; et al.	2005-07-21
Pharmceutical composition for treatment of wounds conntaining blood plasma or serum App 20050142208 - Yoo, Won Min ; et al.	2005-06-30
Interleukin-2 gene transferred lymphokine activated killer cells App 20050095230 - Yoo, Nae Choon ; et al.	2005-05-05
Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 App 20040247562 - Lee, Sang Yup ; et al.	2004-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.